NBIX Exercise Disclosure
Morrow George J · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$0
Morrow George J Director
NBIX
Transaction date
Nov 3, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed same day
NBIX daily price context
Close on/before transaction
$164.85
Nov 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option on Common Stock
- Quantity / price
- 7,200 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001068754-26-000009
Filing cohort
Transactions in this filing
Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$3.14M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $16.2K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $201.97K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $150.46K |
| Neurocrine Biosciences Inc NBIX | Exercise | Nov 3, 2026 | $386.21K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $251.59K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $98.22K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $244.49K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $219.09K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 3, 2026 | $15.82K |
| Neurocrine Biosciences Inc NBIX Current | Exercise | Nov 3, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 2, 2026 | $627.19K |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 2, 2026 | $190.78K |
| Neurocrine Biosciences Inc NBIX | Exercise | Nov 2, 2026 | $402.3K |
| Neurocrine Biosciences Inc NBIX | Exercise | Nov 2, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Sale | Nov 2, 2026 | $275.45K |